Anticholinesterases: medical applications of neurochemical principles.
Cholinesterases form a family of serine esterases that arise in animals from at least two distinct genes. Multiple forms of these enzymes can be precisely localized and regulated by alternative mRNA splicing and by co- or posttranslational modifications. The high catalytic efficiency of the cholinesterases is quelled by certain very selective reversible and irreversible inhibitors. Owing largely to the important role of acetylcholine hydrolysis in neurotransmission, cholinesterase and its inhibitors have been studied extensively in vivo. In parallel, there has emerged an equally impressive enzyme chemistry literature. Cholinesterase inhibitors are used widely as pesticides; in this regard the compounds are beneficial with concomitant health risks. Poisoning by such compounds can result in an acute but usually manageable medical crisis and may damage the CNS and the PNS, as well as cardiac and skeletal muscle tissue. Some inhibitors have been useful for the treatment of glaucoma and myasthenia gravis, and others are in clinical trials as therapy for Alzheimer's dementia. Concurrently, the most potent inhibitors have been developed as highly toxic chemical warfare agents. We review treatments and sequelae of exposure to selected anticholinesterases, especially organophosphorus compounds and carbamates, as they relate to recent progress in enzyme chemistry.
Millard
C B
CB
U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Grounds, MD 21010-5425, USA.
Broomfield
C A
CA
D000110:Acetylcholinesterase / Q000502:physiology; D000375:Aging; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology / Q000506:poisoning / Q000627:therapeutic use; D002802:Cholinesterases / Q000502:physiology; D006801:Humans; D018377:Neurotransmitter Agents / Q000502:physiology
D002800:Cholinesterase Inhibitors; D018377:Neurotransmitter Agents; D000110:Acetylcholinesterase; D002802:Cholinesterases